387 related articles for article (PubMed ID: 28094444)
1. The Current State of NAD
Schiedel M; Robaa D; Rumpf T; Sippl W; Jung M
Med Res Rev; 2018 Jan; 38(1):147-200. PubMed ID: 28094444
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
Neugebauer RC; Sippl W; Jung M
Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
Aljada A; Dong L; Mousa SA
Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin functions and modulation: from chemistry to the clinic.
Carafa V; Rotili D; Forgione M; Cuomo F; Serretiello E; Hailu GS; Jarho E; Lahtela-Kakkonen M; Mai A; Altucci L
Clin Epigenetics; 2016; 8():61. PubMed ID: 27226812
[TBL] [Abstract][Full Text] [Related]
5. NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
Schemies J; Uciechowska U; Sippl W; Jung M
Med Res Rev; 2010 Nov; 30(6):861-89. PubMed ID: 19824050
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).
Lawson M; Uciechowska U; Schemies J; Rumpf T; Jung M; Sippl W
Biochim Biophys Acta; 2010; 1799(10-12):726-39. PubMed ID: 20601279
[TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry of sirtuin inhibitors.
Chen L
Curr Med Chem; 2011; 18(13):1936-46. PubMed ID: 21517778
[TBL] [Abstract][Full Text] [Related]
8. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
Trapp J; Jung M
Curr Drug Targets; 2006 Nov; 7(11):1553-60. PubMed ID: 17100594
[TBL] [Abstract][Full Text] [Related]
9. An update on lysine deacylases targeting the expanding "acylome".
Olsen CA
ChemMedChem; 2014 Mar; 9(3):434-7. PubMed ID: 24375937
[TBL] [Abstract][Full Text] [Related]
10. Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.
Trapp J; Jochum A; Meier R; Saunders L; Marshall B; Kunick C; Verdin E; Goekjian P; Sippl W; Jung M
J Med Chem; 2006 Dec; 49(25):7307-16. PubMed ID: 17149860
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin deacetylases as therapeutic targets in the nervous system.
Langley B; Sauve A
Neurotherapeutics; 2013 Oct; 10(4):605-20. PubMed ID: 24037427
[TBL] [Abstract][Full Text] [Related]
12. Targeting Sirtuins: Substrate Specificity and Inhibitor Design.
Rajabi N; Galleano I; Madsen AS; Olsen CA
Prog Mol Biol Transl Sci; 2018; 154():25-69. PubMed ID: 29413177
[TBL] [Abstract][Full Text] [Related]
13. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
Van Dyke MW
ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
[TBL] [Abstract][Full Text] [Related]
14. Current advances in the synthesis and antitumoral activity of SIRT1-2 inhibitors by modulation of p53 and pro-apoptotic proteins.
Botta G; De Santis LP; Saladino R
Curr Med Chem; 2012; 19(34):5871-84. PubMed ID: 22998567
[TBL] [Abstract][Full Text] [Related]
15. Promising drug discovery strategies for sirtuin modulators: what lessons have we learnt?
Garg G; Singh AK; Singh S; Rizvi SI
Expert Opin Drug Discov; 2021 Aug; 16(8):915-927. PubMed ID: 33880981
[TBL] [Abstract][Full Text] [Related]
16. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).
Huber K; Schemies J; Uciechowska U; Wagner JM; Rumpf T; Lewrick F; Süss R; Sippl W; Jung M; Bracher F
J Med Chem; 2010 Feb; 53(3):1383-6. PubMed ID: 20030343
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin modulators: an updated patent review (2012 - 2014).
Mellini P; Valente S; Mai A
Expert Opin Ther Pat; 2015 Jan; 25(1):5-15. PubMed ID: 25435179
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial sirtuins.
Huang JY; Hirschey MD; Shimazu T; Ho L; Verdin E
Biochim Biophys Acta; 2010 Aug; 1804(8):1645-51. PubMed ID: 20060508
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in inhibitors of sirtuin1/2: an update and perspective.
Zhou Z; Ma T; Zhu Q; Xu Y; Zha X
Future Med Chem; 2018 Apr; 10(8):907-934. PubMed ID: 29642711
[TBL] [Abstract][Full Text] [Related]
20. Sirtuins and disease: the road ahead.
Carafa V; Nebbioso A; Altucci L
Front Pharmacol; 2012; 3():4. PubMed ID: 22319497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
